Publication:

Erythropoietin treatment leads to reduced blood glucose levels and body mass: Insights from murine models

Date

Date

Date
2010
Journal Article
Published version

Citations

Citation copied

Katz, O., Stuible, M., Golishevski, N., Lifshitz, L., Tremblay, M., Gassmann, M., Mittelman, M., & Neumann, D. (2010). Erythropoietin treatment leads to reduced blood glucose levels and body mass: Insights from murine models. Journal of Endocrinology, 205(1), 87–95. https://doi.org/10.1677/JOE-09-0425

Abstract

Abstract

Abstract

Erythropoietin (EPO) regulates proliferation and differentiation of erythroid precursor cells into erythrocytes. The last decade has revealed non-renal sites of EPO production and extrahematopoietic expression of the EPO-receptor (EPO-R), thus suggesting that EPO has pleiotropic functions. Here we addressed the interplay between EPO / glucose metabolism / body weight, by employing a panel of relevant experimental murine models. The models focused on situations of increased EPO levels, including EPO injected C57BL/6 and BALB/c mice, as

Metrics

Downloads

2 since deposited on 2010-01-22
Acq. date: 2025-11-12

Views

2 since deposited on 2010-01-22
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

  • Katz, O
    affiliation.icon.alt
  • Stuible, M
    affiliation.icon.alt
  • Golishevski, N
    affiliation.icon.alt
  • Lifshitz, L
    affiliation.icon.alt
  • Tremblay, M
  • Gassmann, M
    affiliation.icon.alt
  • Mittelman, M
    affiliation.icon.alt
  • Neumann, D
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
205

Number

Number

Number
1

Page range/Item number

Page range/Item number

Page range/Item number
87

Page end

Page end

Page end
95

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2010

Date available

Date available

Date available
2010-01-22

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
0022-0795

Additional Information

Additional Information

Additional Information
Disclaimer. This is not the definitive version of record of this article. This manuscript has been accepted for publication in Journal of Endocrinology, but the version presented here has not yet been copy edited, formatted or proofed. Consequently, the Society for Endocrinology accepts no responsibility for any errors or omissions it may contain. The definitive version is now freely available at 10.1677/JOE-09-0425. © 2010 Society for Endocrinology

OA Status

OA Status

OA Status
Hybrid

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

2 since deposited on 2010-01-22
Acq. date: 2025-11-12

Views

2 since deposited on 2010-01-22
Acq. date: 2025-11-12

Citations

Citation copied

Katz, O., Stuible, M., Golishevski, N., Lifshitz, L., Tremblay, M., Gassmann, M., Mittelman, M., & Neumann, D. (2010). Erythropoietin treatment leads to reduced blood glucose levels and body mass: Insights from murine models. Journal of Endocrinology, 205(1), 87–95. https://doi.org/10.1677/JOE-09-0425

Hybrid Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image